These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32216005)
41. Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Weir DL; Laing ED; Smith IL; Wang LF; Broder CC Virol J; 2014 Feb; 11():40. PubMed ID: 24576301 [TBL] [Abstract][Full Text] [Related]
42. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry. Fu L; Hu H; Liu Y; Jing Z; Li W Virology; 2017 May; 505():1-11. PubMed ID: 28213271 [TBL] [Abstract][Full Text] [Related]
43. Entry of Classical Swine Fever Virus into PK-15 Cells via a pH-, Dynamin-, and Cholesterol-Dependent, Clathrin-Mediated Endocytic Pathway That Requires Rab5 and Rab7. Shi BJ; Liu CC; Zhou J; Wang SQ; Gao ZC; Zhang XM; Zhou B; Chen PY J Virol; 2016 Oct; 90(20):9194-208. PubMed ID: 27489278 [TBL] [Abstract][Full Text] [Related]
44. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency. Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030 [TBL] [Abstract][Full Text] [Related]
45. JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin. Mayberry CL; Soucy AN; Lajoie CR; DuShane JK; Maginnis MS J Virol; 2019 Apr; 93(8):. PubMed ID: 30700597 [TBL] [Abstract][Full Text] [Related]
46. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. Saso W; Tsukuda S; Ohashi H; Fukano K; Morishita R; Matsunaga S; Ohki M; Ryo A; Park SY; Suzuki R; Aizaki H; Muramatsu M; Sureau C; Wakita T; Matano T; Watashi K Biochem Biophys Res Commun; 2018 Jun; 501(2):374-379. PubMed ID: 29730285 [TBL] [Abstract][Full Text] [Related]
47. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus. Yan H; Li W Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274 [TBL] [Abstract][Full Text] [Related]
48. Strategies to inhibit entry of HBV and HDV into hepatocytes. Urban S; Bartenschlager R; Kubitz R; Zoulim F Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844 [TBL] [Abstract][Full Text] [Related]
49. A dileucine motif is involved in plasma membrane expression and endocytosis of rat sodium taurocholate cotransporting polypeptide (Ntcp). Stross C; Kluge S; Weissenberger K; Winands E; Häussinger D; Kubitz R Am J Physiol Gastrointest Liver Physiol; 2013 Nov; 305(10):G722-30. PubMed ID: 24008362 [TBL] [Abstract][Full Text] [Related]
51. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes. Yan R; Zhang Y; Cai D; Liu Y; Cuconati A; Guo H PLoS One; 2015; 10(6):e0129889. PubMed ID: 26070202 [TBL] [Abstract][Full Text] [Related]
52. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection. Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847 [TBL] [Abstract][Full Text] [Related]
54. Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential. Chen S; Zhang L; Chen Y; Fu L J Med Chem; 2022 Oct; 65(19):12546-12561. PubMed ID: 36111355 [TBL] [Abstract][Full Text] [Related]
55. The enhancement role of Matrigel on HBV infection in HepG2-NTCP cells. Song J; Ou G; Lai X; Tian X; Wang L; Zhang K; Wang L; Zhang X; Zhao C; Zhuang H; Xiang K; Li T J Virol Methods; 2022 Jan; 299():114345. PubMed ID: 34728272 [TBL] [Abstract][Full Text] [Related]
56. Heparin at physiological concentration can enhance PEG-free in vitro infection with human hepatitis B virus. Choijilsuren G; Jhou RS; Chou SF; Chang CJ; Yang HI; Chen YY; Chuang WL; Yu ML; Shih C Sci Rep; 2017 Oct; 7(1):14461. PubMed ID: 29089529 [TBL] [Abstract][Full Text] [Related]
57. Efficient delivery of HBV NLS siRNAs into HepG2.2.15 cells for HBV inhibition through novel recombinant preS1‑tP proteins. Zeng Y; Li Z; Shang J; Kang Y Int J Mol Med; 2018 Aug; 42(2):1181-1189. PubMed ID: 29786106 [TBL] [Abstract][Full Text] [Related]
58. Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors. Kirstgen M; Lowjaga KAAT; Müller SF; Goldmann N; Lehmann F; Glebe D; Baringhaus KH; Geyer J Viruses; 2021 Apr; 13(4):. PubMed ID: 33921515 [TBL] [Abstract][Full Text] [Related]
59. Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids. Kirstgen M; Lowjaga KAAT; Müller SF; Goldmann N; Lehmann F; Alakurtti S; Yli-Kauhaluoma J; Glebe D; Geyer J Sci Rep; 2020 Dec; 10(1):21772. PubMed ID: 33303817 [TBL] [Abstract][Full Text] [Related]
60. Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis. Devadas D; Koithan T; Diestel R; Prank U; Sodeik B; Döhner K J Virol; 2014 Nov; 88(22):13378-95. PubMed ID: 25210183 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]